| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 6,945,000 | 12,306,000 | 11,706,000 | 11,555,000 | | Cost of Revenue | 3,880,000 | 7,092,000 | 6,664,000 | 6,870,000 | | | Gross Profit | 3,065,000 | 5,214,000 | 5,042,000 | 4,685,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,652,000 | 2,794,000 | 2,419,000 | 2,472,000 | | Non Recurring | 94,000 | 24,405,000 | 81,000 | 73,000 | | Others | 121,000 | 201,000 | 206,000 | 194,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,198,000 | (22,186,000) | 2,336,000 | 1,946,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (39,000) | (354,000) | 104,000 | 95,000 | | Earnings Before Interest And Taxes | 1,159,000 | (20,300,000) | 2,344,000 | 1,954,000 | | Interest Expense | 312,000 | 644,000 | 623,000 | 650,000 | | Income Before Tax | 847,000 | (20,944,000) | 1,721,000 | 1,304,000 | | Income Tax Expense | 288,000 | (4,910,000) | 655,000 | 509,000 | | Minority Interest |
-
| 2,240,000 | (96,000) | (87,000) | | | | Net Income From Continuing Ops | 559,000 | (16,034,000) | 1,066,000 | 795,000 | | | Non-recurring Events | | Discontinued Operations | 131,000 | 2,000 | 1,000 | (3,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 690,000 | (16,032,000) | 1,067,000 | 792,000 | | Preferred Stock And Other Adjustments | (29,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $661,000 | ($16,032,000) | $1,067,000 | $792,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
